Qualification of academic facilities for small-scale automated manufacture of autologous cell-based products
Academic centres, hospitals and small companies, as typical development settings for UK regenerative medicine assets, are significant contributors to the development of autologous cell-based therapies. Often lacking the appropriate funding, quality assurance heritage or specialist regulatory experti...
Saved in:
Main Authors: | , , , , , , , |
---|---|
Format: | Default Article |
Published: |
2014
|
Subjects: | |
Online Access: | https://hdl.handle.net/2134/25986 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|